Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAmneal Pharmaceuticals Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | $0.19 | $0.20 | $0.19 |
| Q2 2026 | 1 | $0.22 | $0.22 | $0.22 |
| Q3 2026 | 1 | $0.24 | $0.25 | $0.25 |
| Q4 2026 | 1 | $0.28 | $0.29 | $0.29 |
Amneal Pharmaceuticals Inc Earnings Date And Information
Amneal Pharmaceuticals Inc last posted its earnings results on Thursday, October 30th, 2025. The company reported $0.17 earnings per share for the quarter, topping analysts' consensus estimates of $0.13 by $0.04. The company had revenue of 784.51 M for the quarter and had revenue of 2.79 B for the year. Amneal Pharmaceuticals Inc has generated $0 earnings per share over the last year ($-0.38 diluted earnings per share) and currently has a price-to-earnings ratio of 789.15. Amneal Pharmaceuticals Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Amneal Pharmaceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | N/A | $0.01 | N/A | $773.86 M | $784.51 M |
| 08/07/2025 | Q2 2025 | N/A | $0.07 | N/A | $744.56 M | $724.51 M |
| 05/07/2025 | Q1 2025 | N/A | $0.04 | N/A | N/A | $695.42 M |
| 02/28/2025 | Q4 2024 | $0.15 | -$0.10 | -0.25 | N/A | $730.52 M |
| 11/12/2024 | Q3 2024 | N/A | -$0.00 | N/A | $693.78 M | $702.47 M |
| 08/09/2024 | Q2 2024 | $0.14 | $0.02 | -0.12 | $657.52 M | $701.78 M |
| 05/08/2024 | Q1 2024 | N/A | -$0.30 | N/A | N/A | $659.19 M |
| 03/14/2024 | Q4 2023 | N/A | -$0.40 | N/A | N/A | $616.98 M |
| 11/08/2023 | Q3 2023 | N/A | $0.06 | N/A | N/A | $620.04 M |
| 08/08/2023 | Q2 2023 | N/A | $0.08 | N/A | N/A | $599.05 M |
| 05/09/2023 | Q1 2023 | N/A | -$0.07 | N/A | N/A | $557.54 M |
| 03/03/2023 | Q4 2022 | N/A | -$0.04 | N/A | N/A | $609.76 M |
| 11/07/2022 | Q3 2022 | N/A | -$0.02 | N/A | N/A | $545.56 M |
| 08/08/2022 | Q2 2022 | N/A | -$0.80 | N/A | N/A | $559.36 M |
| 05/06/2022 | Q1 2022 | N/A | -$0.04 | N/A | N/A | $497.63 M |
| 03/01/2022 | Q4 2021 | N/A | -$0.04 | N/A | N/A | $536.90 M |
| 11/08/2021 | Q3 2021 | N/A | -$0.03 | N/A | N/A | $528.59 M |
| 08/09/2021 | Q2 2021 | $0.18 | $0.10 | -0.08 | N/A | $535.08 M |
| 05/07/2021 | Q1 2021 | $0.18 | $0.05 | -0.13 | N/A | $493.11 M |
| 03/01/2021 | Q4 2020 | N/A | -$0.02 | N/A | N/A | $510.03 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Amneal Pharmaceuticals Inc Earnings: FAQ's
In the previous quarter, Amneal Pharmaceuticals Inc (:AMRX) reported $0.17 earnings per share (EPS) to beat the analysts' consensus estimate of $0.13 by $0.04.
The conference call for Amneal Pharmaceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for Amneal Pharmaceuticals Inc's latest earnings report can be read online.
Amneal Pharmaceuticals Inc (:AMRX) has a recorded annual revenue of $2.79 B.
Amneal Pharmaceuticals Inc (:AMRX) has a recorded net income of $-116,886,000.Amneal Pharmaceuticals Inc has generated $-0.38 earnings per share over the last four quarters.
Amneal Pharmaceuticals Inc (:AMRX) has a price-to-earnings ratio of 789.15 and price/earnings-to-growth ratio is 9.96.